Q1 2022 revenues of €1,760m, +9.1% vs. Q1 2021, despite a significant decrease in COVID related revenues Q1 2022 total revenue organic growth2 of +1.1% vs. Q1 2021, impacted by the reduction
Regulatory News: Eurofins Scientific ("Eurofins") (Paris:ERF), a global scientific leader in bioanalytical testing and clinical diagnostics testing, announces that its subsidiary, Eurofins Clinical